- CJC-1295 No DAC & Ipamorelin is a research peptide blend studied in models involving growth hormone secretagogue signaling, pituitary-axis activity, GH pulse dynamics, IGF-1 pathway research, and endocrine regulation
The highest dose for weight loss treatment is often 2.4 mg weekly, but not everyone needs or reaches this amount
Cardiovascular Risk Reduction : Ozempic is also approved for reducing the risk of major adverse cardiovascular events (such as heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes and established cardiovascular disease
When longevity clinics talk about "peptide therapy," they're usually referring to synthetic or bioidentical versions of these signaling molecules, administered to influence specific biological processes: growth hormone release, tissue repair, inflammation regulation, immune modulation, or metabolic function